Literature DB >> 33322514

Desmoid Tumors Characteristics, Clinical Management, Active Surveillance, and Description of Our FAP Case Series.

Lupe Sanchez-Mete1, Virginia Ferraresi2, Mauro Caterino3, Aline Martayan4, Irene Terrenato5, Elena Mannisi1, Vittoria Stigliano1.   

Abstract

(1) Background: desmoid tumors (DTs) are common in patients with familial adenomatous polyposis (FAP). An active surveillance approach has been recently proposed as a valuable alternative to immediate treatment in some patients. However, no clear indication exists on which patients are suitable for active surveillance, how to establish the cut-off for an active treatment, and which imaging technique or predictive factors should be used during the surveillance period. (2)
Results: we retrospectively analyzed 13 FAP patients with DTs. A surveillance protocol consisting of scheduled follow-up evaluations depending on tumor location and tissue thickening, abdominal computed tomography (CT) scan/Magnetic resonance imaging (MRI) allowed prompt intervention in 3/11 aggressive intra-abdominal DTs, while sparing further interventions in the remaining cases, despite worrisome features detected in three patients. Moreover, we identified a possible predictive marker of tumor aggressiveness, i.e., the "average monthly growth rate" (AMGR), which could distinguish patients with very aggressive/life-threatening tumor behavior (AMGR > 0.5) who need immediate active treatment, from those with stable DTs (AMGR < 0.1) in whom follow-up assessments could be delayed. (3)
Conclusion: surveillance protocols may be a useful approach for DTs. Further studies on larger series are needed to confirm the usefulness of periodic CT scan/MRI and the value of AMGR as a prognostic tool to guide treatment strategies.

Entities:  

Keywords:  CT scan; MRI; desmoid tumors; familial adenomatous polyposis (FAP); prognostic factors; surveillance protocol; tumor growth

Year:  2020        PMID: 33322514      PMCID: PMC7764110          DOI: 10.3390/jcm9124012

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  71 in total

1.  Desmoid tumors -- a characterization of patients seen at Mayo Clinic 1976-1999.

Authors:  Taya Fallen; Marcia Wilson; Bruce Morlan; Noralane M Lindor
Journal:  Fam Cancer       Date:  2006       Impact factor: 2.375

Review 2.  Desmoid Tumors in Familial Adenomatous Polyposis.

Authors:  Maria Laura DE Marchis; Francesco Tonelli; Davide Quaresmini; Domenica Lovero; David Della-Morte; Franco Silvestris; Fiorella Guadagni; Raffaele Palmirotta
Journal:  Anticancer Res       Date:  2017-07       Impact factor: 2.480

3.  Risk factors predicting desmoid occurrence in patients with familial adenomatous polyposis: a meta-analysis.

Authors:  A Sinha; P P Tekkis; D C Gibbons; R K Phillips; S K Clark
Journal:  Colorectal Dis       Date:  2010-06-02       Impact factor: 3.788

4.  Chemotherapy in patients with desmoid tumors: a study from the French Sarcoma Group (FSG).

Authors:  D Garbay; A Le Cesne; N Penel; C Chevreau; P Marec-Berard; J-Y Blay; M Debled; N Isambert; A Thyss; E Bompas; O Collard; S Salas; J-M Coindre; B Bui; A Italiano
Journal:  Ann Oncol       Date:  2011-03-28       Impact factor: 32.976

5.  Vinblastine and methotrexate for desmoid fibromatosis in children: results of a Pediatric Oncology Group Phase II Trial.

Authors:  Stephen X Skapek; William S Ferguson; Linda Granowetter; Meenakshi Devidas; Antonio R Perez-Atayde; Louis P Dehner; Fredric A Hoffer; Roseanne Speights; Mark C Gebhardt; Gary V Dahl; Holcombe E Grier
Journal:  J Clin Oncol       Date:  2007-02-10       Impact factor: 44.544

6.  Early experience with percutaneous cryoablation of extra-abdominal desmoid tumors.

Authors:  Jennifer L Kujak; Patrick T Liu; Geoffrey B Johnson; Matthew R Callstrom
Journal:  Skeletal Radiol       Date:  2009-09-21       Impact factor: 2.199

7.  Desmoid tumour biology in patients with familial adenomatous polyposis coli.

Authors:  S Schiessling; M Kihm; P Ganschow; G Kadmon; M W Büchler; M Kadmon
Journal:  Br J Surg       Date:  2013-01-18       Impact factor: 6.939

8.  Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors.

Authors:  Alexander J F Lazar; Daniel Tuvin; Shohrae Hajibashi; Sultan Habeeb; Svetlana Bolshakov; Empar Mayordomo-Aranda; Carla L Warneke; Dolores Lopez-Terrada; Raphael E Pollock; Dina Lev
Journal:  Am J Pathol       Date:  2008-10-02       Impact factor: 4.307

9.  Risk Factors for the Development of Desmoid Tumor After Colectomy in Patients with Familial Adenomatous Polyposis: Multicenter Retrospective Cohort Study in Japan.

Authors:  Yasufumi Saito; Takao Hinoi; Hideki Ueno; Hirotoshi Kobayashi; Tsuyoshi Konishi; Fumio Ishida; Tatsuro Yamaguchi; Yasuhiro Inoue; Yukihide Kanemitsu; Naohiro Tomita; Nagahide Matsubara; Koji Komori; Kenjiro Kotake; Takeshi Nagasaka; Hirotoshi Hasegawa; Motoi Koyama; Hideki Ohdan; Toshiaki Watanabe; Kenichi Sugihara; Hideyuki Ishida
Journal:  Ann Surg Oncol       Date:  2016-07-07       Impact factor: 5.344

10.  Evaluation of management of desmoid tumours associated with familial adenomatous polyposis in Dutch patients.

Authors:  M H Nieuwenhuis; E M Mathus-Vliegen; C G Baeten; F M Nagengast; J van der Bijl; A D van Dalsen; J H Kleibeuker; E Dekker; A M Langers; J Vecht; F T Peters; R van Dam; W G van Gemert; W N Stuifbergen; W R Schouten; H Gelderblom; H F A Vasen
Journal:  Br J Cancer       Date:  2010-11-09       Impact factor: 7.640

View more
  1 in total

1.  Using genotype to assist clinical surveillance: a retrospective study of Chinese familial adenomatous polyposis patients.

Authors:  Sai Ge; Duo Cheng; Xuhui Zhang; Ting Xu; Zhenghang Wang; Fengxiao Dong; Lan Su; Jinlei Song; Jia Wang; Jian Li; Lin Shen; Xicheng Wang
Journal:  Am J Cancer Res       Date:  2022-09-15       Impact factor: 5.942

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.